ADS-ADEA 2016* # – Panel Discussion#1 – Integrated diabetes care – from conceptualization to implementation#10 – Pneumococcal vaccination and incident pneumonia in type 2 diabetes: The Fremantle Diabetes Study Phase II#100 – Autophagy plays a role in regulation of glucose-stimulated insulin secretion in pancreatic beta-cells under different nutrient conditions#101 – Overcoming clinical inertia in glycaemic therapy for T2D in primary care: Theory & practice#102 – Nutrition and indigenous health: learning from the past and the future#103 – Diabetes-Specific Discharge Planning for Older People with Diabetes. #104 – Theoretical mapping of SMART programs: A quality improvement tool#105 – Development and Validation of the Type 1 and Type 2 Diabetes Stigma Assessment Scales (DSAS-1 and DSAS-2)#106 – A qualitative study of how Australian health care professionals form their convictions – viewed through the lens of self-blood glucose monitoring in patients with non-insulin treated diabetes mellitus#107 – Blood glucose monitoring; Is it fundamental to best practice inpatient care?#108 – Insulin initiation in primary care for patients with type 2 diabetes: 24 month follow-up of the Stepping Up trial#109 – Diabetes Management in Cancer Patients: Changes in Nursing Practice#11 – Pro-oxidant enzyme Nox5 plays a crucial role in diabetic nephropathy#110 – How fast is fast enough? New insulins for improved prandial glucose control#111 – More than just the carbs - a new look at carbohydrate counting #112 – Novel and emerging psychological issues in preventing and managing diabetes-related complications#113 – Online depression treatment for people living with diabetes: randomised controlled trial findings#114 – Evaluation and Recommendations - Review of a Mentoring Program for Diabetes Educators in Australia #115 – Why and How We Developed Consensus Guidelines for Diabetes management in Cancer Patients#116 – Post-operative Glycaemic Management in Coronary Artery Graft Surgery Patients Transitioning from an Intravenous Insulin Infusion#117 – Informing older people with diabetes about glucose lowering medicines#118 – An Online Self-Management Intervention for Young Adults with Diabetes: The Guided Self-Determination Program#119 – Two clinical cases to illustrate an integrated nurse practitioner approach to improving the management of people with complex chronic disease comorbidities#12 – Decreased MMP-3 activity is associated with changes in renal morphology in mice with long duration of diabetes. #120 – The Multifaceted Roles of Adipose Tissue: Therapeutic Targets for Diabetes and Beyond#121 – Noncoding genome function in pancreas development and disease#122 – The impact of diabetes and blood glucose in the inpatient setting#123 – Inpatient hyperglycaemia in special situations: Critical illness and steroid therapy#124 – The role of the Credentialled Diabetes Educator in the hospital#125 – Management of hyperglycaemia in hospital – what is the evidence?#126 – High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22#127 – Identification and Characterization of Genes Associated With Hyperglycaemia and Reduced Insulin Secretion in Mice and Men#128 – Genetic deletion of the Set7 lysine methyltransferase attenuates renal damage in a mouse model of diabetic nephropathy#129 – Overexpression of Fructose Bisphosphatase 2 in muscle increases insulin-mediated glucose uptake. #13 – Targeting the C5a-C5aR1 Signalling Axis in Diabetic Nephropathy#130 – Liver-Specific Deletion Of The Mitochondrial Stress Gene UBL-5 Leads To Liver Failure#131 – Enhancing nuclear NAD+ via transgenic overexpression of the salvage enzyme NMNAT1 alters muscle fibre type and whole-body energy metabolism#132 – Identifying the Role of Depot Specific Adipocyte Precursors in the Development of Obesity and Type 2 Diabetes#133 – Il-1 signalling in macrophages is required for normal glucose homeostasis in the obese state#134 – Maternal lipoproteins and gut microbiome in early pregnancy#135 – Evaluation of fasting blood glucose as an initial diagnostic test for gestational diabetes mellitus (GDM).#136 – Gestational Diabetes – A reduction in neonatal hypoglycaemia with new diagnostic criteria and treatment targets#137 – Good4Mum: Delivering enhanced care to women with previous gestational diabetes in general practice#138 – PCOS is characterised by a specific epigenetic signature in peripheral blood mononuclear cells: A pilot study#139 – Relationship between omega-3 polyunsaturated fatty acids and insulin resistance is sex-dependent: a systematic review and meta-analysis of randomized controlled trials#14 – Novel regulation of diabetic cardiomyopathy and cardiac ischaemia-reperfusion injury#140 – The effect of exercise on visceral fat in type 2 diabetes.#141 – Exercise capacity (VO2max) is reduced in Type 2 diabetes mellitus (T2DM) but not Type 1 (T1DM), and is not due to diastolic dysfunction#142 – Challenges in the design and analysis of clinical trials#143 – The trials and tribulations of getting a drug to market#144 – How systematic reviews can work for you: in practice and in research#145 – Health economics: an introduction and overview#146 – Can you Standardise Diabetes Education and Treatment for Children?#147 – Rules of engagement for the clinician in the use of social media#148 – Using an app to engage and educate people with diabetes in western sydney#149 – Cognitive computing and personalised wellness information in diabetes, with Medtronic and IBM Watson Health#15 – Targeting Connective Tissue Growth Factor (CTGF/CCN2) Protects Against Progressive Non-Alcoholic Steatohepatitis in a Preclinical Model Induced by High-Fat Feeding and Type 2 Diabetes.#150 – Diabetes Hypertechnology#151 – Update on type 1 diabetes prevention#152 – Cardiovascular benefits of SGLT2 inhibitors – not a wee effect!#153 – SGLT2 inhibitors and renal disease#154 – LEADER - More good news for the patients with type 2 diabetes#155 – Diabetic kidney disease: An energy crisis?#156 – The role of vasoactive hormones in experimental diabetic nephropathy#157 – Diabetic kidney disease: new insights into cardiovascular risk#158 – Evolving strategies for the detection, monitoring and management of diabetic kidney disease#159 – A Comparison of Glycaemic Control in Adults and Adolescents With Type 1 Diabetes When Using a Closed Loop Insulin Delivery System Overnight Versus Sensor-Augmented Pump With Low Glucose Suspend At Home: A Randomised Crossover Study#16 – Rapid oral uptake and trafficking of AGE modified bovine serum albumin in healthy mice.#160 – Overnight Glucose and Counter-regulatory Hormone Profiles in Type 1 Diabetes Adults during Closed Loop Insulin Delivery vs Sensor Augmented Pump with Low Glucose Suspend#161 – Comparison of service utilisation and outcomes in young adults aged 16-25 managed with multiple daily injections(MDI) and continuous subcutaneous insulin infusion (CSII)#162 – Earlier onset of exposure and greater early pharmacokinetic and pharmacodynamic effects for faster-acting insulin aspart vs. insulin aspart using continuous subcutaneous insulin infusion#163 – Psychometric Validation of the Novel Glucose Monitoring Experiences Questionnaire (GME-Q) among Adults with Type 1 Diabetes#164 – Assessing the impact of insulin pump therapy on behaviour, mood, cognition and glycaemia in youth with Type 1 Diabetes – a randomised controlled trial#165 – Faster-acting insulin aspart demonstrates higher early insulin exposure and greater early glucose-lowering effect vs. insulin aspart across a clinically relevant dose range#166 – Regulation of alpha cell function and fatty acid levels by hyperinsulinaemia after islet cell transplantation in Type 1 diabetes #167 – Identification of a Novel Mitochondrial Uncoupler that Does Not Depolarise the Plasma Membrane#168 – A Trans-omics Approach to Identify Novel Regulators of Hepatic Metabolism#169 – Mitochondrial NAD+ Biosynthesis Regulates Hepatic Energy Metabolism#17 – Differing effects of two isocaloric exercise programs on metabolic profile and skeletal muscle extracellular matrix in obese mice#171 – The metabolic effects of activating pyruvate dehydrogenase in vivo by dichloroacetate treatment.#172 – IL-22 alters feeding behaviour in obese mice #173 – The roles of SIRT1 in maternal obesity-induced metabolic disorders in the offspring#174 – Abundance of Collinsella in the gut microbiome at 16 weeks gestation is positively correlated with insulin levels in overweight and obese women#175 – The highs and lows of international travel with T1D and coeliac disease: A personal journey #176 – Pregnancy Outcomes in Women with Diabetes – Lessons Learned from Clinical Research#177 – Artificial Pancreas during Type 1 Diabetes Pregnancy#178 – Reduction in the risk of developing type 2 diabetes (T2D) with liraglutide 3.0 mg in people with prediabetes from the SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled trial #179 – The 5:2 STOP Study: A pilot study to compare the metabolic effects and safety of weight loss via intermittent fasting versus standard continuous energy restriction in patients with Type 1 diabetes and overweight or obesity#18 – Preventive role of two exercise programs from high fat diet induced extracellular matrix accumulation in fat depots#180 – Higher glomerular filtration rate is related to insulin resistance independently of obesity in healthy non-diabetic adults#181 – Evaluating the Obesity Paradox in Type 2 Diabetes with Real-world Data from Primary Care System#182 – Insulin-sensitive overweight/obese adults remain as insulin-sensitive as lean subjects over 6 years#183 – Five-year outcomes of a randomized trial of gastric band surgery in overweight but not obese people with type 2 diabetes#184 – Gut inflammation and the microbiota as drivers of type 1 diabetes#185 – The metabolic consequences of fecal microbiota transplantation (FMT) in mice#186 – Innate immune-microbiota interactions protect against cachexia#187 – Contemporary management of diabetes and its cardiovascular and renal complications#188 – Helping people achieve sustainable goals with lifestyle#189 – The role of weight loss surgery in diabetic patients#19 – Supporting Effective Self-management From the Clinic to the Community#190 – Pharmacotherapy#191 – Muscle microvascular blood flow and glucose regulation#192 – The effects of sugar on the brain#193 – Brain regulation of blood glucose levels#2 – Discovery of a Novel Class of Lipids with Anti-diabetic and Anti-inflammatory Effects#20 – Lipid synthesis and storage in human metabolic disorders#201 – Investigating adipose tissue lipid metabolism as a key regulator of whole-body glucose tolerance#202 – Lipid Droplet Proteome Reveals Role of Key Proteins in the Pathogenesis of Hepatic Insulin Resistance#203 – Association Between Gut Specific G-Coupled Protein Receptors and Resistance to Diet-Induced Obesity in C57BL6/J MICE.#204 – Molecular markers of beta-cell mortality#205 – Angiotensin II causes β-cell dysfunction through endoplasmic reticulum stress induced inflammation#206 – UBL-5 is essential for sustaining pancreatic β-cell function and mass in mice#207 – GLT25D1 regulates the secretion of HMW adiponectin and lipid accumulation#208 – Investigating the role of the System-L amino acid transporter LAT1 in the development of pancreatic beta-cell dysfunction and type 2 diabetes#209 – Beta-Cell Regeneration in Zebrafish; Metformin and Consequences for Alpha and Delta Cells#21 – Identification of an interferome nexus as a paradoxical negative regulator of adipogenesis and positive regulator of local and systemic insulin sensitivity#210 – Heparan sulfate (HS) loss in Type 2 diabetes (T2D)-prone db/db beta cells increases susceptibility to oxidative stress#211 – Insulin secretion impairment in Sirt6 knockout pancreatic β cells is mediated by suppression of the FoxO1-Pdx1-Glut2 pathway#212 – BPA and Octylphenol induced endoplasmic reticulum stress by modulating calcium homeostasis in mouse pancreas#213 – French maritime pine bark extract-based supplement suppress hepatic inflammation and improve insulin sensitivity#214 – Role of c-Cbl in muscle energy metabolism in relation to obesity#215 – Matrine eliminates hepatosteatosis and glucose intolerance in high fructose-fed mice by suppressing ER stress associated de novo lipogenesis in the liver#216 – Calbindin-D9k and ER Stress in Hypoxia-Induced Diabetes Mellitus like Model#218 – Comparative genotypic and phenotypic analysis of surrogate monocytic-like cell lines and human peripheral blood monocytes#219 – Effect of skeletal muscle-specific knockout of the lysine acetyltransferase, GCN5, on skeletal muscle insulin sensitivity#22 – Insulin Action in the Fat Cell#221 – Functional Magnetic Resonance Imaging (MRI) changes in Type 1 Diabetes with and without Renal Hyperfiltration#222 – Sulfonylurea therapy, hypoglycaemia, glycaemic variability and changes in ventricular repolarisation#223 – Metformin usage in adults with type 1 diabetes in the Australian National Diabetes Information Audit and Benchmarking (ANDIAB) Initiative#224 – Psychosocial factors in patients presenting with diabetic ketoacidosis#225 – Meta-analysis of the outcomes of twin pregnancies complicated by gestational diabetes mellitus#226 – Is hearing impairment another diabetes complication?#227 – Reversal of Type 2 Diabetes in Youth who adhere to a Very Low Energy Diet; the SHAKE IT pilot study#228 – Metabolic effect of high-calorie meals on type 1 diabetic individuals with and without nephropathy (The FinnDiane Study)#229 – Beta-cell function interpolated from fasting plasma C-peptide is a robust marker of disease progression and response to immune therapy in children and young adults with type 1 diabetes.#23 – Retinol Binding Protein 4 is a Biomarker and Cause of Insulin Resistance and Metabolic Syndrome through Activation of the Innate and Adaptive Immune Systems#230 – Suboptimal overnight glucose control behaviours common in adults with Type 1 diabetes: An assessment tool and need for education.#231 – High rates of obesity in young adults with type 1 diabetes (T1D)#232 – Investigation of cardiac biomarkers in ambulatory type 1 diabetes patients#233 – HbA1c and other cardiovascular risk factors: outcomes in a tertiary multidisciplinary Young Adults Diabetes Service#234 – Clinical characteristics in adult vs juvenile-onset type 1 diabetes#235 – Brittle Diabetes: Time to Break a Delicate Diagnosis?#236 – A comparison of GP and specialist diabetes clinic based adult Type 1 diabetes glucose self-care and control.#237 – Insulin pump therapy practices in young adults with type 1 diabetes in a tertiary hospital young adults transition clinic#238 – Management of eating disorders in type 1 diabetes#239 – Managing lipids in Type 1 Diabetes (T1D) – how are we doing?#24 – Putting words into action - NADC member benefits and highlights 2016#240 – Euglycaemic DKA in a patient with LADA after treatment with empagliflozin.#241 – Intermittent Fasting: appears an effective and safe strategy for weight loss and metabolic control in Type 2 Diabetes#242 – Effect of blueberry tea on improving metabolic and vascular function in people with type 2 diabetes - A Pilot Study#243 – Vitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort#244 – Mixed Meal Testing: Effective Clinical Tool or Outdated Investigation?#245 – Early weight loss responders to liraglutide 3.0 mg had greater weight loss, regression to normoglycaemia, and reduced T2D development at 3 years vs early non-responders: SCALE Obesity and Prediabetes#246 – Characteristics of individuals developing type 2 diabetes in the SCALE Obesity and Prediabetes randomised, double-blind, liraglutide vs placebo trial#247 – Weight loss and associated improvements in cardiometabolic risk factors with liraglutide 3.0 mg in the SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled 3-year trial#248 – Gastric band surgery for overweight but not obese people is a cost-effective treatment for type 2 diabetes#249 – Salicylates intervention improves several cardiometabolic outcomes: meta-analysis of RCTs#25 – Findings of the Australian National Diabetes Audit (ANDA) 2015#250 – Improvement in IWQOL-Lite-derived health utility score with liraglutide 3.0 mg versus placebo over 3 years in prediabetes#251 – Diabetes distress and depression in type 2 diabetes: The Fremantle Diabetes Study Phase II#252 – Young onset type 2 diabetes: Out of Touch and Out of Time#253 – Sydney Samoan Community perspectives on the diabetes epidemic#254 – Are the diagnoses of diabetes and sarcopenia associated with patients' progress in inpatient rehabilitation? A systematic literature review#255 – Age of diabetes onset: glycaemic control and hypoglycaemia benefit with new insulin glargine 300 U/mL in T2DM#256 – Switching from twice-daily basal insulin to once-daily new insulin glargine 300 U/mL (Gla-300): an analysis in people with T2DM (EDITION 1 and 2)#257 – Real-world experience with Dapagliflozin in people with type-2 diabetes living in Western Sydney: Beneficial impact on biomarkers and reasons for discontinuation.#258 – A one-year prospective experience using Optifast® vs glucagon-like peptide-1 analogues in obese adult patients with type 2 diabetes#259 – Effect of exenatide in combination with insulin in patients with type 2 diabetes mellitus on insulin requirement, weight and glycaemic control – prospective audit on local clinical protocol (follow-up result)#26 – Funding a pump clinic#260 – Response to exenatide over 2 years in very obese type 2 diabetics.#261 – Decreased stomal output in response to liraglutide: a case study#262 – Factors associated with insulin-induced weight gain in an Australian type 2 diabetes outpatient clinic.#263 – Prescription of hypoglycaemic medications in people with renal impairment and type 2 diabetes attending Australian general practice#264 – Improving the Transition of Care of Inpatients with Type 2 Diabetes#265 – Fournier’s syndrome: a life threatening complication of SGLT2 inhibition in poorly controlled diabetes mellitus#266 – The changing management of type 2 diabetes - metabolic/bariatric surgery in Western Sydney#267 – Efficacy of an intensive and integrated team-based model of care for severely obese patients with type 2 diabetes in a public hospital setting #268 – Factors Associated with Insulin Adherence among Patients with Type 2 Diabetes: The MOSAIc Study#269 – Silent Diabetic Ketoacidosis: Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycaemic Diabetic Ketoacidosis#27 – How to run telemedicine in your diabetes clinic#270 – Elderly Patients with Type 2 Diabetes Mellitus: Role of HbA1c as predictor of hypoglycaemia?#271 – Diabetes in the Elderly#272 – Time series modelling to forecast prehospital Emergency Medical Service demand for diabetic emergencies#273 – The role of paternal factors in young onset type 2 diabetes (YT2DM)#274 – A Poll to determine ethnic differences of diabetes in Australia#275 – Observational study of Diabetic Ketoacidosis admissions at two tertiary hospital sites in Western Australia from 2008-2010.#276 – Early admission glycaemia predicts glycaemic extremes in hospitalised patients with diabetes#277 – Identification of novel plasma biomarkers of rapid eGFR decline in type 2 diabetes.#278 – An inpatient audit of diabetes in an Australian tertiary hospital utilising the UK National Diabetes Inpatient Audit tool.#279 – Predictive value of serum testosterone for type 2 diabetes risk assessment in men#28 – Digital Health: Empowering Your Future Self?#280 – Diabetes and its risk factors in a Samoan community.#281 – Healthcare Use and Expenditure for Diabetes in Bangladesh#282 – An Audit of the Cardio-Metabolic risk profile of adults attending a tertiary referral hospital Diabetes Clinic in South Western Sydney.#283 – A Hospital snapshot of Obesity and Type 2 Diabetes#284 – Factors associated with glycaemic control among patients with type 2 diabetes attending diabetes centres: Results from ANDA 2015#285 – The Impact of Diabetes on Health Related Quality of Life: Results from a Case Control Study in Bangladesh#286 – The impact of moderate-intensity continuous and high-intensity interval training on plasma miRNA profile of hyperglycaemic patients#287 – Diabetes in hospitalised patients; a whole of hospital single day evaluation.#288 – Diabetes and Urbanisation in Papua New Guinea: A Call to Action#289 – Chest radiography – An over-utilised investigation in diabetic ketoacidosis?#29 – New innovative models of care and funding#291 – Does diabetes influence a person’s functional independence whilst in hospital?#292 – The Aboriginal Health Practitioner Diabetes Mentoring Pilot Study#293 – Prevalence of Diabetes Before and After Lung Transplantation#294 – Hypoglycaemia: Prevalence and characterisitics in non-diabetic adults with Cystic Fibrosis, attending a centre in Australia#295 – Novel CFTR modifiers may rapidly restore β-cell function in patients with cystic fibrosis#296 – Pembrolizumab Induced Diabetes – A Case Series#297 – Challenges in the Management of Rociletinib-Induced Hyperglycaemia#298 – A Retrospective Audit of Pancreatectomy Surgery and Diabetes#299 – The management of unstable diabetes in a cancer population – a retrospective audit#3 – Metabolic subtypes and all-cause and cardiovascular mortality in patients with type 1 diabetes (the FinnDiane Study)#30 – The contribution of glycaemic status to the progression of kidney disease among Indigenous Australians with and without albuminuria– the eGFR follow-up study#300 – The Effect of the Patient-Physician Relationship on Insulin Progression, Diabetes Distress, Adherence, and HbA1c Control over Time: Insights from the MOSAIc Study#301 – DATABETES: introducing online psychosocial research participation and service evaluation in a community centre for children with type 1 and their families#302 – Improved mental health in diabetes: are we there yet?#303 – Diabetic ketoacidosis and severe hypertriglyceridemia as a consequence of an atypical antipsychotic agent#304 – Awareness, knowledge and attitudes on diabetes mellitus of Sri Lankan patient population attending a Colombo suburb Hospital.#305 – Preventing Diabetes in people with Depression in primary health care (PDD trial): a pilot study#306 – Gaining clinical experience using continuous glucose monitoring system (CGM) in people with type 2 diabetes mellitus (T2DM)#307 – Frequency of and reasons for self-monitoring of blood glucose among Australians with insulin-treated diabetes. Results from the YourSAY: Glucose Monitoring study#308 – Cost Effectiveness of FreeStyle Libre® Flash Glucose Monitoring System from an Australian Health Care Payer Perspective#309 – Smartphone Application for Self Blood Glucose Monitoring & Disease Management- A Case Report#31 – Soluble urokinase plasminogen activator receptor (suPAR) levels and decline in estimated glomerular filtration rate (eGFR) in patients with diabetes#310 – The use of continuous blood glucose monitoring in adults with type 1 diabetes mellitus #311 – Accu-Chek Blood Glucose Monitoring System Global Strip Handling Study#312 – Low glucose level on glucose tolerance test during pregnancy: do we need to worry?#313 – Younger age at conception adversely affects outcomes of pregnancy in young women aged 16-25 with type I diabetes (T1D)#314 – First trimester screening for gestational diabetes: A risk prediction model combining maternal clinical and biomarker parameters #316 – Pregnant women should be risk-stratified to prevent unnecessary glucose challenge#317 – Adherence to guideline-based early testing for gestational diabetes in a Victorian tertiary centre#318 – Maternal Characteristics and Perinatal Outcomes for Women Treated with Metformin in Gestational Diabetes#319 – Effects of Metformin Exposure during Pregnancy on the Epigenome#32 – Trajectories of eGFR decline over a four year period: the eGFR Follow-up Study#320 – Women After Gestational Diabetes (WAGs) pilot program: Engaging women in a lifestyle modification program post gestational diabetes.#321 – The Effect Of Salt Versus Placebo Supplementation On Haematocrit Levels In Type Two Diabetes Mellitus#322 – Gain and Loss Framing of Complications Messages in Diabetes-specific Media#323 – Prevalence and independent factors associated with diabetes-related and non-diabetes-related foot ulcers in a representative inpatient population#324 – Defining the utility of clinical vascular testing to identify those with diabetic foot complications#325 – High Rate of Diabetes Lower Limb Amputation in Indigenous Australians: Is There a Causal Factor?#326 – Observational study of admissions to the inpatient Multidisciplinary Diabetic Foot Unit at Fiona Stanley Hospital: experiences from the first year of operation#327 – Clinical Associations Across a Spectrum of Ankle Brachial Index Readings in Patients with Diabetes Mellitus#328 – Diabetes-related major lower limb amputation in rural and Indigenous Western Australians – Missed opportunities for earlier intervention?#329 – Telemedicine: Harnessing Technology to Manage Diabetic Foot Ulcers in Rural Areas -a systematic review#33 – Effect of Empagliflozin on Nephropathy in Subgroups by Age: Results from EMPA-REG OUTCOME#330 – Micro- and neurovascular complications in type 2 diabetes mellitus - the prevalence and potential risk factors#331 – Mechanical noise improves the vibration perception threshold of the foot in people with diabetic neuropathy#332 – Excoriation (skin-picking) disorder in a patient with Double Diabetes leading to multiple finger amputations#333 – Modern Pedorthics saves limbs and keeps you on your toes.#334 – Relationships among neuropathies, vascular reactivity and bone in the diabetic foot#335 – Effects of GLP-1 Agonism on Peripheral Nerve Function in Type 2 Diabetes#336 – Peripheral Neuropathy in the Hands of People with Diabetes Mellitus#337 – Co-designing an integrated patient-centred health service for co-morbid diabetes and chronic kidney disease.#338 – A systematic review investigating the incidence of chronic kidney disease in diabetes#339 – Management of Diabetes Mellitus in Inpatients with Chronic Diabetic Kidney Disease#34 – Tumour Necrosis Factor-alpha Receptor 1 and 2 are Reduced in patients with Type 1 Diabetes and Hyperfiltration#340 – A Diabeto‘genic’ Syndrome: HNF1B mutation and a severe case of anuric renal failure causing perinatal mortality#341 – Health-worker led Retinal Imaging, Diabetes-related Eye Health Education and Lifestyle Survey Administration as a Model for Diabetic Retinopathy Screening in Indigenous Australians with Diabetes#342 – Prevalence and treatment of metabolic pattern dyslipidaemia (MPD) in patients with established coronary disease – an Australian outpatient study#343 – Standard of in-patient hyperglycaemia management in patients with acute ischemic stroke and the impact of standardised insulin chart, on delivery of care in these patients.#344 – Specialised Physiotherapy for in-patients with Diabetes leads to improved outcomes#345 – Case-conference style consultations in GP practices with Specialist and Primary care teams: an efficient way to improve diabetes outcomes for our population#346 – Comparison of management of in-patient hyperglycaemia by standard specialist care vs basal-bolus-booster insulin in a tertiary referral hospital#347 – Patient and Healthcare Provider Attitudes Towards Insulin Therapy in a Tertiary Referral Hospital in South West Sydney#348 – Impact of the NSW Adult Subcutaneous insulin prescribing chart on glucose management at the John Hunter Hospital, Newcastle#349 – Diabetes related medication errors: An analysis of Nepean Blue Mountains LHD IIMS report#35 – Determinants of offloading devices to reduce plantar pressure in the diabetic foot#350 – Postprandial hyperglycaemia and diabetes management#351 – Integrated Care Pathway (ICP) for Discharge Preparation of Patients with Diabetes (PWD)#352 – Developing a computer program that can assist GPs to choose antidiabetic medications in according to the Australian Diabetes Society Guidelines and Pharmaceutical Benefits Schemes.#353 – HbA1c reduction and engagement in an ambulatory insulin stabilisation program#354 – Evaluation of the Accu-Chek Guide® blood glucose meter in an Australian setting#355 – Major amputation following a diabetic foot ulcer – too late to turn around?#356 – In-Depth Molecular Analysis to assist Health Care Professionals with Useful Dietary Choices#357 – Living with Your Insulin Pump -a self management resource#358 – Hospital Frequent Fliers; Commonalities seen between patients with Diabetes re-presenting to hospital#359 – A proposed model of care: Identification of variable and suitable measures for routine data collection along with care-pathways and psychosocial interventions to optimise emotional well–being and glycaemic control of young people aged 18-25 years with type 1 diabetes#36 – Annual incidence and risk factors for developing infection in people with diabetes-related foot ulcers#360 – Diabetes and Oral Health Care: A Scoping Review#361 – Does training positively enhance staff perception and change in management of hyperglycaemia in the inpatient setting ?#362 – Use of Continuous Glucose Monitoring (CGM) to improve outcomes for Indigenous clients with Type 2 diabetes living in Remote Communities of Australia. (Clinical Practice)#363 – Psychosocial aspects of continuous subcutaneous insulin infusion (CSII) therapy#364 – Taking the emerging closed loop insulin delivery systems from in-clinic studies to home use: a clinical research nurse perspective.#365 – Looking through a Health Literacy lens: What does Health Literacy mean for ordinary people?#366 – Identified need of clear guidelines aimed at medical and nursing staff for the discharge of people with diabetes following hypoglycaemic events#367 – The association between self-compassion and diabetes distress: Results from the second Diabetes MILES- Australia (MILES-2) study#368 – Diabetes Educators’ role in diabetes eye care for Aboriginal and Torres Strait Islander people#369 – Upskilling General Practice: Diabetes Educator and Practice Nurse Perspectives#37 – Assessment of Microcirculation in the Foot of People with Diabetes with Laser Speckle Contrast Imaging#370 – Impact of the Check, Think and Act Resource on Undergraduate Podiatry Students' Learning #371 – An Introduction to Type One 101 - The Telethon Type 1 Diabetes Family Centre Babysitters Training Program#372 – Parent and carer perspectives of Paediatric Type-1 Diabetes care delivered in a regional setting#373 – Preferences, perceptions and experiences of peer support: A national survey of Australian adults with diabetes#374 – FlexIT Training for Health Professionals: A Novel Approach for Flexible Insulin Adjustment Education#375 – Validation of the Summary of Self-Care Behaviours Scale#376 – Just Beat-It! Dia-Beat-It!#377 – Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus #378 – Desmond (Diabetes Education and Self-Management for Ongoing and Newly Diagnosed). Quality Development Assessment of Assessors – the point of difference.#379 – A Novel Support Program Improves Quality of Care in Newly Diagnosed Patients with Type 1 Diabetes#38 – New role for the RN-CDE, expanding health professional care of people with type 2 diabetes in primary care#380 – The high frequency and frequent variations of inpatient hyper- and hypoglycaemia in a large teaching hospital.#381 – An evaluation: Educating primary healthcare nurses in general practice to better manage patients with diabetes#382 – The InDiGO Project: Colouring outside the lines of conventional inpatient diabetes management#383 – A Burning Issue – Exploring Burnout in Australian Diabetes Educators#384 – CDE Journal Club – A review of its place in clinical practice#385 – Responding to need: the development of a Continuous Subcutaneous Insulin Infusion (CSII) Clinical Practice Guide, Patient/Carer Consent and Inpatient Rate Record.#386 – Evaluation of Education Retained by Carers and Adolescents Post Insulin Pump Commencement#387 – Integrated Care Pathway (ICP) for Discharge Preparation of Patients with Diabetes (PWD)#388 – In with the new, out with the old? – Applying new GDM diagnostic criteria in a community setting#389 – Initiating injectable therapy in hospital versus the home: experiences of people with type 2 diabetes and diabetes team providing care#39 – Caring for older people with diabetes: issues, challenges and shared solutions#390 – Planning for the best start: an evaluation of pregnancy seminars for women with type 1 or type 2 diabetes #391 – Reviewing routine annual diabetes complications assessments, for patients with Cystic Fibrosis Related Diabetes (CFRD)#4 – Therapeutic inertia for glycaemic and blood pressure control in patients with T2DM and the cardiovascular consequences: A Longitudinal study on 1.1 million patients#40 – Kidney disease in type 1 diabetes: lessons learned from the DCCT/EDIC Study#41 – Diabetes Technology: Vices and Virtues#42 – How to address the psychological needs of people with diabetes?#43 – Competence for All: Australianising Inter-professional Competency Based CPD in Diabetes#44 – Boosted confidence in carbohydrate counting for adult pumpers despite numeracy challenges#45 – CSII in a young Type 2 woman preparing for pregnancy#46 – Deveolpment of a self-advocacy tool for high school students with type 1 diabetes#47 – Identifying women with abnormal glucose metabolism after gestational diabetes#48 – How can registries and data improve the trajectory of care for young people with type 1 diabetes?#49 – Mind the gap- building transition services for youth with diabetes#5 – Dementia risk factors differ by age at onset of type 2 diabetes mellitus: The Fremantle Diabetes Study Phase I#50 – Driving and Diabetes#51 – Engaging women and clinicians with pre-pregnancy care#52 – Long non coding RNAs in human pancreatic beta-cells#53 – Overlap in genetic susceptibility to type 1 and type 2 - lessons from mouse models#54 – Finding Novel beta cell genes using the Collaborative Cross#55 – Supersized: epigenetics in very large mammal models#56 – Quantifying and Predicting Mean A1C Reductions for Exenatide QW and BID: Importance of Baseline A1C and Other Patient Characteristics#57 – Addition or Switch to Insulin Therapy in Patients Treated with GLP-1 Receptor Agonists: A Real World Study in 66,583 Patients#58 – Hypoglycaemia in Elderly Patients with Type 2 Diabetes in Subacute Hospital Care is Associated with increased Mortality#59 – Audit of Diabetes Management Guidelines for the Cancer Centre during the Pilot Phase#6 – Proton pump inhibitor use, mortality and endothelial dysfunction in type 2 diabetes: The Fremantle Diabetes Study Phase II#60 – Effect of Empagliflozin on Cardiovascular Death in Subgroups by Age: Results from EMPA-REG OUTCOME#61 – Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial outcomes#62 – Effects of linagliptin on glycemic control and albuminuria in type 2 diabetes - the MARLINA–T2D™ trial#63 – Fenofibrate Reduces Uric Acid Levels and Gout Events in Type 2 Diabetes: Results from the Field Study#64 – Obesity without Muscle Insulin Resistance in High-Starch Diet Mice#65 – Role of the hepatoportal system in the reversal of insulin resistance in rats#66 – The role of lipid droplet protein, Perilipin 5, in glucose and lipid metabolism#67 – The free fatty acid receptor GPR84: a new player in glucose tolerance and mitochondrial function?#68 – Antagonism of peripheral Y1 receptor ameliorates diet-induced obesity and improves glucose tolerance#69 – Osmotic mini-pump delivered streptozotocin allows targeted and consistent induction of type 2 diabetes in rats.#7 – The Prevalence of Diabetes Mellitus and its Association with Stroke Inpatient Outcomes #70 – Screening for Small Molecules to Treat Type 2 Diabetes, Based on Disruption of the Interaction between Protein Kinase C epsilon and RACK2#71 – Dynamics of blood DNA methylation changes associated with Type 2 Diabetes Mellitus: a longitudinal study#72 – Improving Diabetes Care of People with Intellectual Disability#73 – Six month evaluation of ComDiab - a nurse led community based education program for people affected by type 2 diabetes#74 – DESMOND (Diabetes Education and Self-Management for the Ongoing and Newly Diagnosed): Is it only for the newly diagnosed?#75 – Are we too reassuring to our patients with young onset type 2 diabetes?#76 – Exploring the stages of wound/ulcer healing and its management: ? A paradigm shift for diabetes educators#77 – Knowledge gaps surrounding insulin use in adults with type 2 diabetes#78 – The case for multidisciplinary input: psychosocial screening for young adults attending a multidisciplinary diabetes clinic#79 – Diabetes Education Program and Service Needs of Young Adults with Type 1 Diabetes#8 – Prevalence of diabetes amongst patients hospitalised with decompensated heart failure and their outcomes#80 – Diabetes narratives in migrants: How careful analysis of stories can help us rise above the ontological desert of ‘behaviour change’ research#81 – Effects of Antecedent Hypoglycaemia on the Gastric and Cardiac Responses to Subsequent Hypoglycaemia in Health#82 – Evaluation of Closed Loop Performance in Adults with Type 1 Diabetes Undertaking Anaerobic Versus Aerobic Exercise: A Randomised Crossover Study#83 – Predictors of vision loss in type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II#84 – Maternal characteristics and perinatal outcomes of Aboriginal and Europid women with gestational diabetes and diabetes in pregnancy: The PANDORA Study#85 – Pulmonary microvascular disease in diabetes mellitus (DM) subjects detected by exercise echocardiography is not associated with reduced exercise capacity#86 – Use of a glucose alert pathway and connectivity blood glucose meters reduces inattention to hospital diabetes management#87 – Glycaemic variability in Type 1 diabetes patients is better with continuous subcutaneous insulin infusion (CSII) therapy than with multiple daily injection (MDI) treatment.#88 – Associations between age, age at diagnosis and diabetes duration with vascular events in type 2 diabetes#89 – Investigating the molecular basis and therapeutic potential of the HO-1 adiponectin axis#9 – Utilisation of prehospital emergency medical services for hyperglycaemia#90 – Hot and Sweet: Human brown fat beyond thermoregulation#91 – Obesity-induced adipose tissue macrophages: culprits or construction workers?#92 – Diabetes, Obesity and the Central Role of the Adipocyte in Maintaining Systemic Lipid Homeostasis#93 – MicroRNAs of human insulin producing cells in pancreas, gallbladder and brain#94 – Pancreatic transdiffereniation of human and mouse hepatocytes in FRG mice#95 – High fat fed NOD.B10 foz/foz mice have a type 2 diabetes phenotype without evidence of islet beta-cell dysfunction in vitro#96 – Overexpression of the Unfolded Protein Response Gene Herpud1 leads to impaired insulin secretion but protection from high fat induced glucose intolerance#97 – PTPN1, a novel target for limiting interferon signalling in β-cells to protect against autoimmune diabetes#98 – Deletion of PKCε in macrophages improves beta cell function#99 – Hypoxia inducible factor-1α (HIF-1α) is required for β-cell survival in Type 1 diabetes (T1D) caused by immunological insults